Ebola virion proteins expressed from venezuelan equine encephalitis (VEE) virus replicons
US6984504B2 · kind B2 · utility
4Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 29, 2003 |
| Grant date | Jan 10, 2006 |
| Priority date | — |
| Expiry date | Feb 21, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/36162
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Using the Ebola GP, NP, VP24, VP30, VP35 and VP40 virion proteins, a method and composition for use in inducing an immune response which is protective against infection with Ebola virus is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.